Larofen Plus (Pseudoephedrine Hydrochloride, Ibuprofen)

Pseudoephedrine hydrochloride stimulates α‑adrenergic receptors in the nasal mucosa, causing blood‑vessel constriction. This reduces swelling and opens the nasal passages, helping to relieve congestion and improve breathing.

The specific dose and frequency of Larofen Plus are determined by the prescribing clinician based on the patient’s age, weight, medical condition and other medications. Patients should follow the healthcare professional’s instructions and the product label.

Safety information for pregnancy and lactation is limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Larofen Plus.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Larofen Plus combines pseudoephedrine with ibuprofen, offering both vasoconstrictive decongestion and COX‑inhibition for pain and inflammation. Compared with products that pair pseudoephedrine with acetaminophen, ibuprofen provides stronger anti‑inflammatory action but may carry a higher gastrointestinal risk.

Larofen Plus should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablet container tightly closed, protect it from moisture, heat and direct sunlight to maintain product stability.

Larofen Plus is taken orally with a full glass of water. It is usually swallowed whole and not chewed or crushed, unless otherwise directed by a healthcare professional.

Serious risks include severe allergic reactions (anaphylaxis), significant hypertension, gastrointestinal bleeding, and rare skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms like rash, swelling, vomiting blood or sudden high blood pressure.

Individuals with known hypersensitivity to pseudoephedrine, ibuprofen or any component of the formulation should avoid Larofen Plus. It is also contraindicated in patients with uncontrolled hypertension, severe coronary artery disease, active gastrointestinal ulceration, or those taking monoamine oxidase inhibitors.